- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02616549
Multicomponent Yoga Intervention for Major Depressive Disorder
December 7, 2015 updated by: University of Pennsylvania
A Randomized Study of a Comprehensive Yoga Intervention for Patients With Major Depressive Disorder With Incomplete Response to Antidepressants
The purpose of this study is to evaluate the efficacy of a multi-component yoga intervention featuring Sudarshan Kriya Yoga (SKY) as an adjunctive treatment for patients with Major Depressive Disorders with incomplete response to antidepressants.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
According to the World Health Organization, compared to two hundred health conditions, depression is ranked as the second leading cause of disability worldwide.
The annual prevalence of Major Depressive Disorder (MDD) in the United States is estimated at 7% and the lifetime risk approximately 17%.
Depression is associated with approximately 75% of all deaths by suicide, resulting in immense suffering for families and society at large.
83 billion dollars are spent per year on treatment and lost productivity related to the disorder.
Current treatments for MDD have remission rates between 35-50%.
Patients who respond to treatment, but do not experience clinical remission are at markedly increased risk for relapse.
Approximately 50% of patients treated with two trials of antidepressant interventions do not achieve clinical remission.
Consequently, novel evidence-based treatment modalities that can further treat this devastating disorder are needed.
Mind-body interventions constitute a large and diverse group of practices that reduce both stress and inflammation and are increasingly being evaluated in the treatment of MDD The 2007 NHIS concluded that 16.6% of U.S. adults, representing 34.1 million Americans, used at least one mind-body intervention in the past year.
Initial studies with different mind-body interventions have been shown to improve outcomes in MDD.
A recent meta-analysis gave a Grade B for current evidence for the use of yoga as an intervention for MDD.
Sudarshan Kriya Yoga (SKY) is a advanced yogic breathing intervention that has been reported to relieve symptoms of major depressive disorder and generalized anxiety disorder.
In MDD, SKY can correct the P300 amplitude, decrease plasma cortisol levels and increase plasma prolactin levels.
In a small-scale randomized controlled trial, 45 consenting inpatients meeting criteria for DSM-IV severe, melancholic depression were randomized to receive SKY, electroconvulsive therapy (ECT) or imipramine treatment for four weeks (Janakiramaiah et al. 2000).
Consequently, the rigorous evaluation of a multicomponent yogic intervention featuring SKY as an adjunctive treatment for adults with MDD warrants further study.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Mood & Anxiety Disorders Research and Treatment Program
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 67 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- DSM-IV Major Depressive Disorder
- Able to give informed consent
- Aged 18-67
- Currently in outpatient care for MDD
- On a stable antidepressant regimen for at least 2 months
- 17-item Hamilton Depression Score >14 at screening & baseline visit
Exclusion Criteria:
- Currently in crisis requiring inpatient treatment
- Bipolar Disorder, Psychotic Disorder, ADHD, Substance Use Disorder
- Pregnancy, Epilepsy
- Initiating psychotherapy or other yoga/meditation program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Waitlist Control
|
|
|
Experimental: Sudarshan Kriya Yoga
|
A manual-based yoga program featuring a yoga-breathing meditation technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
17-item Hamilton Depression Rating Scale
Time Frame: Baseline to 2 month
|
Baseline to 2 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Beck Depression Inventory
Time Frame: Baseline to 2 month
|
Baseline to 2 month
|
|
Beck Anxiety Inventory
Time Frame: Baseline to 2 month
|
Baseline to 2 month
|
|
Columbia Suicide Severity Rating Scale
Time Frame: Baseline, 1 month, 2 month
|
Baseline, 1 month, 2 month
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Serum Inflammatory Markers
Time Frame: Baseline, 1 month, 2 month
|
Baseline, 1 month, 2 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
November 23, 2015
First Submitted That Met QC Criteria
November 24, 2015
First Posted (Estimate)
November 30, 2015
Study Record Updates
Last Update Posted (Estimate)
December 8, 2015
Last Update Submitted That Met QC Criteria
December 7, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 820672
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Gang WangWest China Hospital; The First Hospital of Hebei Medical University; Tianjin... and other collaboratorsRecruitingMajor Depressive Disorder (MDD) | Depression - Major Depressive DisorderChina
-
Brian MickeyNational Institute of Mental Health (NIMH)RecruitingMajor Depressive Episode | Depression - Major Depressive Disorder | Treatment-Resistant Major Depressive DisorderUnited States
-
Unity Health TorontoUniversity of Toronto; Toronto Metropolitan UniversityRecruitingMajor Depressive Disorder (MDD) | Major Depressive Episode | Treatment-Resistant Major Depressive DisorderCanada
-
Second Affiliated Hospital of Tsinghua UniversityNot yet recruiting
-
First People's Hospital of HangzhouNot yet recruitingMajor Depressive Disorder
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Recruiting
-
Shandong Provincial HospitalShandong UniversityRecruiting
-
Engrail Therapeutics INCCompletedMajor Depressive DisorderUnited Kingdom
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Stanford UniversityNational Institute of Mental Health (NIMH)Recruiting
Clinical Trials on Sudarshan Kriya Yoga
-
Lawson Health Research InstituteWithdrawn
-
Mount Sinai Hospital, CanadaNova Scotia Health Authority; St. Joseph's Health Care London; Atlas Institute... and other collaboratorsRecruitingPTSD | Quality of Life | Pain | Anxiety | Depressive Symptoms | Post Traumatic Stress DisorderCanada
-
University of Alabama at BirminghamWithdrawnStress, Psychological
-
University of Alabama at BirminghamM.D. Anderson Cancer CenterCompletedStress | Stress, Psychological | Anxiety | Stress, Physiological | Happiness | Resilience | Mental Well BeingUnited States
-
Lawson Health Research InstituteArt of Living FoundationTerminatedHealthcare Workers | Compassion Fatigue | Psychological Trauma | Job Stress | Healthcare Providers | Workplace StressCanada
-
Lawson Health Research InstituteWithdrawn
-
Lawson Health Research InstituteCompletedPost Traumatic Stress DisorderCanada
-
University of Wisconsin, MadisonThe Dana FoundationTerminated